Aug,2025
Categories: History
Time of issue:2026-01-14 00:00
Received the third Breakthrough Therapy Designation by China NMPA for 2L+ CRC with KRAS G12C Mutation
Categories: History
Time of issue:2026-01-14 00:00
Received the third Breakthrough Therapy Designation by China NMPA for 2L+ CRC with KRAS G12C Mutation